BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 10022912)

  • 1. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
    Tong W; Pollard JW
    Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B; Pollard JW
    Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA; Swarbrick A; Lee CS; Cornish AL; Sutherland RL
    Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
    Wang W; Smith R; Safe S
    Arch Biochem Biophys; 1998 Aug; 356(2):239-48. PubMed ID: 9705214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
    Chen B; Pan H; Zhu L; Deng Y; Pollard JW
    Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK; Obaya AJ; Sedivy JM
    Mol Cell Biol; 1999 Jul; 19(7):4672-83. PubMed ID: 10373516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration.
    Albrecht JH; Rieland BM; Nelsen CJ; Ahonen CL
    Am J Physiol; 1999 Dec; 277(6):G1207-16. PubMed ID: 10600818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
    Leng X; Noble M; Adams PD; Qin J; Harper JW
    Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice.
    Hampl A; Pacherník J; Dvorák P
    Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1.
    Morisaki H; Ando A; Nagata Y; Pereira-Smith O; Smith JR; Ikeda K; Nakanishi M
    Exp Cell Res; 1999 Dec; 253(2):503-10. PubMed ID: 10585273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
    Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW; Nambirajan S; Moffat JG
    Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
    Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
    Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
    Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.